Literature DB >> 6969294

Clinical and immunological associations in myasthenia gravis. 1: Autoantibodies.

H J Sagar, K Gelsthorpe, A Milford-Ward, G A Davies-Jones.   

Abstract

Associations between female sex, HLA B8, positive anti-thyroid microsomal antibody and, to a lesser extent, antinuclear antibody were seen in 34 patients with myasthenia gravis. This supports the concept that the disease is heterogeneous. Anti-DNA antibodies, which were present in 62% of the patients, did not show such associations.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6969294      PMCID： PMC490746          DOI： 10.1136/jnnp.43.11.967

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  9 in total

1.  AN IMMUNOLOGIC SURVEY OF FORTY-EIGHT PATIENTS WITH MYASTHENIA GRAVIS.

Authors:  M M ADNER; J D SHERMAN; C ISE; R S SCHWAB; W DAMESHEK
Journal:  N Engl J Med       Date:  1964-12-24       Impact factor: 91.245

2.  MULTIPLE ANTIBODY PRODUCTION IN MYASTHENIA GRAVIS.

Authors:  H VAN DER GELD; T E FELTKAMP; J VAN LOGHEM; H J OOSTERHUIS; A BIEMOND
Journal:  Lancet       Date:  1963-08-24       Impact factor: 79.321

3.  An easily produced micro-cytotoxic test plate with a further modification of the standard micro-cytotoxic technique for lymphocyte typing.

Authors:  K Gelsthorpe; R W Doughty
Journal:  Med Lab Technol       Date:  1971-01

4.  Assessment of cellular and humoral immunity of myasthenics.

Authors:  S W Huang; J W Rose; R F Mayer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-11       Impact factor: 10.154

5.  Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.

Authors:  J M Lindstrom; M E Seybold; V A Lennon; S Whittingham; D D Duane
Journal:  Neurology       Date:  1976-11       Impact factor: 9.910

6.  Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice.

Authors:  K V Toyka; D B Drachman; D E Griffin; A Pestronk; J A Winkelstein; K H Fishbeck; I Kao
Journal:  N Engl J Med       Date:  1977-01-20       Impact factor: 91.245

7.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

8.  Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange.

Authors:  J Newsom-Davis; A J Pinching; A Vincent; S G Wilson
Journal:  Neurology       Date:  1978-03       Impact factor: 9.910

9.  Myasthenia gravis, autoantibodies, and HL-A antigens.

Authors:  T E Feltkamp; P M van den Berg-Loonen; L E Nijenhuis; C P Engelfriet; A L van Rossum; J J van Loghem; H J Oosterhuis
Journal:  Br Med J       Date:  1974-01-26
  9 in total
  3 in total

1.  Systemic and anti-neuronal auto-antibodies in patients with paraneoplastic neurological disease.

Authors:  J W Moll; H Hooijkaas; B C van Goorbergh; L G Roos; S C Henzen-Logmans; C J Vecht
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

2.  Clinical implementation of anti-acetylcholine receptor antibodies.

Authors:  F E Somnier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

3.  Familial myasthenia gravis.

Authors:  D Honeybourne; P A Dyer; P D Mohr
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-09       Impact factor: 10.154
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.